Thermo Fisher and Qiagen Agree Terms for Acquisition Thermo Fisher Scientific Inc. and QIAGEN N.V. have announced that they have entered into an amendment to their acquisition agreement under which Thermo Fisher has commenced a tender offer to acquire all of the ordinary shares of QIAGEN. The amendment increases the original offer price of €39.00 […]
Thermo Fisher Scientific Inc has today announced it’s intention to acquire FEI. The Board’s of both companies have reached agreement on the deal and it is hoped that FEI’s shareholders will approve the deal such that the acquisition can complete early in 2017. The acquisition will be at $107.50 per share in cash, valuing FEI […]
Thermo Fisher Scientific reports Q4 and full year 2013 results today, January 30 2014. Highlights include revenue growth of 6% for the quarter to $3.47 billion in 2013, versus $3.26 billion in 2012 and revenue for full year 2013 grew 5% to $13.09 billion, versus $12.51 billion a year ago. Also, the acquisition of Life Technologies to add complementary genomics, next-generation sequencing […]